Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response

Previous Article
Genome characterization through dichotomic classes: An analysis of the whole chromosome 1 of A. thaliana
MBE Home
This Issue
Next Article
A Cellular Potts model simulating cell migration on and in matrix environments

2013, 10(1): 221-234. doi: 10.3934/mbe.2013.10.221

Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response

Diego Samuel Rodrigues ^1, and Paulo Fernando de Arruda Mancera ^2,

1.	Universidade de São Paulo, Depto de Matemática Aplicada e Estatística, ICMC, USP, 13560-970, São Carlos, Brazil
2.	Universidade Estadual Paulista, Depto de Bioestatística, IBB, UNESP, 18618-970, Botucatu, Brazil

Received April 2012 Revised September 2012 Published December 2012

Abstract
Related Papers

Dosage and frequency of treatment schedules are important for successful chemotherapy. However, in this work we argue that cell-kill response and tumoral growth should not be seen as separate and therefore are essential in a mathematical cancer model. This paper presents a mathematical model for sequencing of cancer chemotherapy and surgery. Our purpose is to investigate treatments for large human tumours considering a suitable cell-kill dynamics. We use some biological and pharmacological data in a numerical approach, where drug administration occurs in cycles (periodic infusion) and surgery is performed instantaneously. Moreover, we also present an analysis of stability for a chemotherapeutic model with continuous drug administration. According to Norton & Simon [22], our results indicate that chemotherapy is less efficient in treating tumours that have reached a plateau level of growing and that a combination with surgical treatment can provide better outcomes.

Keywords: Norton-Simon hypothesis, chemotherapy, mathematical modelling., Tumour.

Mathematics Subject Classification: Primary: 92B05; Secondary: 37N2.

Citation: Diego Samuel Rodrigues, Paulo Fernando de Arruda Mancera. Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response. Mathematical Biosciences & Engineering, 2013, 10 (1) : 221-234. doi: 10.3934/mbe.2013.10.221

References:

[1]	R. E. Bellman., "Mathematical Methods in Medicine,'', World Scientific Publishing Co. Inc., (1983). Google Scholar
[2]	T. Browder, C. E. Butterfield, B. M. Kraling, B. Shi, B. Marshall, M. S. O'Reilly and J. Folkman, Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer,, Cancer Res., 60 (2000), 1878. Google Scholar
[3]	R. N. Buick, Cellular basis of chemotherapy,, in, (1994). Google Scholar
[4]	L. G. de Pillis and A. E. Radunskaya, A mathematical tumor model model with immune resistance and drug therapy: An optimal control approach,, J. Theor. Med., 3 (2001), 79. doi: 10.1080/10273660108833067. Google Scholar
[5]	L. G. de Pillis, W. Gu, K. R. Fister, T. Head, K. Maples, A. Murugan, T. Neal and K. Yoshida, Chemotherapy for tumors: Analysis of the dynamics and a study of quadratic and linear optimal controls,, Math. Biosc., 209 (2007), 292. doi: 10.1016/j.mbs.2006.05.003. Google Scholar
[6]	A. D'Onofrio, U. Ledzewicz, H. Maurer and H. Schättler, An optimal delivery of combination therapy for tumors,, Math. Biosc., 222 (2009), 13. doi: 10.1016/j.mbs.2009.08.004. Google Scholar
[7]	R. T. Dorr and D. D. Von Hoff, "Cancer Chemotherapy Handbook,'', McGraw-Hill, (1994). Google Scholar
[8]	FEC100 chemotherapy for breast cancer (Written by Jeremy Braybrooke)., Document number: ASWCS09 BR006 [internet] accessed 27/07/2011, available from , (). Google Scholar
[9]	{N. Ferrara and H. P. Gerber}, The role of vascular endothelial growth factor in angiogenesis,, Acta Haematol., 106 (2001), 148. doi: 10.1159/000046610. Google Scholar
[10]	K. R. Fister and J. C. Panetta, Optimal control applied to competing chemotherapeutic cell-kill strategies,, SIAM J. Appl. Math., 63 (2003), 1954. doi: 10.1137/S0036139902413489. Google Scholar
[11]	R. A. Gatenby, Application of competition theory to tumour growth: Implications for tumour biology and treatment,, Eur. J. Cancer, 32A (1996), 722. doi: 10.1016/0959-8049(95)00658-3. Google Scholar
[12]	R. S. Kerbel, Tumour angiogenesis: Past, present and the near future,, Carcinogenesis, 21 (2000), 505. doi: 10.1093/carcin/21.3.505. Google Scholar
[13]	M. Kohandel, S. Sivaloganathan and A. Oza, Mathematical modeling of ovarian cancer treatments: Sequencing of surgery and chemotherapy,, J. Theor. Biol., 242 (2006), 62. doi: 10.1016/j.jtbi.2006.02.001. Google Scholar
[14]	L. G. Marcu and E. Bezak, Neoadjuvant cisplatin for head and neck cancer: simulation of a novel schedule for improved therapeutic ratio,, J. Theor. Biol., 297 (2012), 41. doi: 10.1016/j.jtbi.2011.12.001. Google Scholar
[15]	R. B. Martin, M. E. Fisher, R. F. Minchin and K. L. Teo, Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells,, Math. Biosc., 110 (1992), 221. doi: 10.1016/0025-5564(92)90039-Y. Google Scholar
[16]	R. B. Martin and K. L. Teo, "Optimal Control of Drug Administration in Cancer Chemotherapy,'', World Scientific, (1994). Google Scholar
[17]	R. B. Martin, Optimal control drug scheduling of cancer chemotherapy,, Automatica 28 (1992), 28 (1992), 113. doi: 10.1016/0005-1098(92)90054-J. Google Scholar
[18]	MeadJohnson Oncology Products [internet], http://patient.cancerconsultants.com/druginserts/Cyclophosphamide.pdf., accessed 29/02/2012., (). Google Scholar
[19]	R. D. Mosteller, Simplified calculation of body surface area,, N. Engl. J. Med., (1987). Google Scholar
[20]	S. Mukherjee, "The Emperor of All Maladies: A Biography of Cancer,'', Scribner, (2010). Google Scholar
[21]	F. Nani and H. I. Freedman, A mathematical model of cancer treatment by immunotherapy,, Math. Biosc., 163 (2000), 159. doi: 10.1016/S0025-5564(99)00058-9. Google Scholar
[22]	L. Norton and R. Simon, The Norton-Simon hypothesis revisited,, Cancer Treat. Rep., 70 (1986), 163. Google Scholar
[23]	S. T. R. Pinho, H. I. Freedman and F. K. Nani, A chemotherapy model for the treatment of cancer with metastasis,, Math. Comp. Model., 36 (2002), 773. doi: 10.1016/S0895-7177(02)00227-3. Google Scholar
[24]	S. T. R. Pinho, F. S. Bacelar, R. F. S. Andrade and H. I. Freedman, A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy,, Nonlin. Anal.: Real World Appl., 14 (2013), 815. doi: 10.1016/j.nonrwa.2012.07.034. Google Scholar
[25]	D. S. Rodrigues, S. T. R. Pinho and P. F. A. Mancera, Um modelo matemático em quimio-terapia,, TEMA, 13 (2012), 1. doi: 10.5540/tema.2012.013.01.0001. Google Scholar
[26]	D. S. Rodrigues, P. F. A. Mancera and S. T. R. Pinho, Accessing the effect of metronomic chemotherapy through a simple mathematical model,, 2012, (). Google Scholar
[27]	F. M. Schaebel, Concepts for systematic treatment of micrometastases,, Cancer, 35 (1975), 15. doi: 10.1002/1097-0142(197501)35:1<15::AID-CNCR2820350104>3.0.CO;2-W. Google Scholar
[28]	H. E. Skipper, F. M. Schaebel-Jr. and W. S. Wilcox, Experimental evaluation of potential anticancer agents XIII: on the criteria and kinetics associated with curability of experimental leukemia,, Cancer Chemother. Rep., 35 (1964), 1. Google Scholar
[29]	J. S. Spratt, J. S. Meyer and J. A. Spratt, Rates of growth of human neoplasms: part II,, J. Surg. Oncol., 61 (1996), 68. doi: 10.1002/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E. Google Scholar
[30]	G. S. Stamatakos, E. A. Kolokotroni, D. D. Dionysiou, E. C. Georgiadi and C. Desmedt, An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumour to chemotherapy: mimicking a clinical study,, J. Theor. Biol., 266 (2010), 124. doi: 10.1016/j.jtbi.2010.05.019. Google Scholar
[31]	V. G. Vaidya and F. J. Alexandro Jr., Evaluation of some mathematical models for tumor growth,, Int. J. Biom. Comput., 13 (1982), 19. doi: 10.1016/0020-7101(82)90048-4. Google Scholar
[32]	World Health Organization, http://www.who.int/cancer/en/, accessed 02/03/2012., (). Google Scholar
[33]	R. A. Weinberg, "The Biology of Cancer,'', Garland Science, (2008). Google Scholar

show all references

References:

[1]	R. E. Bellman., "Mathematical Methods in Medicine,'', World Scientific Publishing Co. Inc., (1983). Google Scholar
[2]	T. Browder, C. E. Butterfield, B. M. Kraling, B. Shi, B. Marshall, M. S. O'Reilly and J. Folkman, Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer,, Cancer Res., 60 (2000), 1878. Google Scholar
[3]	R. N. Buick, Cellular basis of chemotherapy,, in, (1994). Google Scholar
[4]	L. G. de Pillis and A. E. Radunskaya, A mathematical tumor model model with immune resistance and drug therapy: An optimal control approach,, J. Theor. Med., 3 (2001), 79. doi: 10.1080/10273660108833067. Google Scholar
[5]	L. G. de Pillis, W. Gu, K. R. Fister, T. Head, K. Maples, A. Murugan, T. Neal and K. Yoshida, Chemotherapy for tumors: Analysis of the dynamics and a study of quadratic and linear optimal controls,, Math. Biosc., 209 (2007), 292. doi: 10.1016/j.mbs.2006.05.003. Google Scholar
[6]	A. D'Onofrio, U. Ledzewicz, H. Maurer and H. Schättler, An optimal delivery of combination therapy for tumors,, Math. Biosc., 222 (2009), 13. doi: 10.1016/j.mbs.2009.08.004. Google Scholar
[7]	R. T. Dorr and D. D. Von Hoff, "Cancer Chemotherapy Handbook,'', McGraw-Hill, (1994). Google Scholar
[8]	FEC100 chemotherapy for breast cancer (Written by Jeremy Braybrooke)., Document number: ASWCS09 BR006 [internet] accessed 27/07/2011, available from , (). Google Scholar
[9]	{N. Ferrara and H. P. Gerber}, The role of vascular endothelial growth factor in angiogenesis,, Acta Haematol., 106 (2001), 148. doi: 10.1159/000046610. Google Scholar
[10]	K. R. Fister and J. C. Panetta, Optimal control applied to competing chemotherapeutic cell-kill strategies,, SIAM J. Appl. Math., 63 (2003), 1954. doi: 10.1137/S0036139902413489. Google Scholar
[11]	R. A. Gatenby, Application of competition theory to tumour growth: Implications for tumour biology and treatment,, Eur. J. Cancer, 32A (1996), 722. doi: 10.1016/0959-8049(95)00658-3. Google Scholar
[12]	R. S. Kerbel, Tumour angiogenesis: Past, present and the near future,, Carcinogenesis, 21 (2000), 505. doi: 10.1093/carcin/21.3.505. Google Scholar
[13]	M. Kohandel, S. Sivaloganathan and A. Oza, Mathematical modeling of ovarian cancer treatments: Sequencing of surgery and chemotherapy,, J. Theor. Biol., 242 (2006), 62. doi: 10.1016/j.jtbi.2006.02.001. Google Scholar
[14]	L. G. Marcu and E. Bezak, Neoadjuvant cisplatin for head and neck cancer: simulation of a novel schedule for improved therapeutic ratio,, J. Theor. Biol., 297 (2012), 41. doi: 10.1016/j.jtbi.2011.12.001. Google Scholar
[15]	R. B. Martin, M. E. Fisher, R. F. Minchin and K. L. Teo, Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells,, Math. Biosc., 110 (1992), 221. doi: 10.1016/0025-5564(92)90039-Y. Google Scholar
[16]	R. B. Martin and K. L. Teo, "Optimal Control of Drug Administration in Cancer Chemotherapy,'', World Scientific, (1994). Google Scholar
[17]	R. B. Martin, Optimal control drug scheduling of cancer chemotherapy,, Automatica 28 (1992), 28 (1992), 113. doi: 10.1016/0005-1098(92)90054-J. Google Scholar
[18]	MeadJohnson Oncology Products [internet], http://patient.cancerconsultants.com/druginserts/Cyclophosphamide.pdf., accessed 29/02/2012., (). Google Scholar
[19]	R. D. Mosteller, Simplified calculation of body surface area,, N. Engl. J. Med., (1987). Google Scholar
[20]	S. Mukherjee, "The Emperor of All Maladies: A Biography of Cancer,'', Scribner, (2010). Google Scholar
[21]	F. Nani and H. I. Freedman, A mathematical model of cancer treatment by immunotherapy,, Math. Biosc., 163 (2000), 159. doi: 10.1016/S0025-5564(99)00058-9. Google Scholar
[22]	L. Norton and R. Simon, The Norton-Simon hypothesis revisited,, Cancer Treat. Rep., 70 (1986), 163. Google Scholar
[23]	S. T. R. Pinho, H. I. Freedman and F. K. Nani, A chemotherapy model for the treatment of cancer with metastasis,, Math. Comp. Model., 36 (2002), 773. doi: 10.1016/S0895-7177(02)00227-3. Google Scholar
[24]	S. T. R. Pinho, F. S. Bacelar, R. F. S. Andrade and H. I. Freedman, A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy,, Nonlin. Anal.: Real World Appl., 14 (2013), 815. doi: 10.1016/j.nonrwa.2012.07.034. Google Scholar
[25]	D. S. Rodrigues, S. T. R. Pinho and P. F. A. Mancera, Um modelo matemático em quimio-terapia,, TEMA, 13 (2012), 1. doi: 10.5540/tema.2012.013.01.0001. Google Scholar
[26]	D. S. Rodrigues, P. F. A. Mancera and S. T. R. Pinho, Accessing the effect of metronomic chemotherapy through a simple mathematical model,, 2012, (). Google Scholar
[27]	F. M. Schaebel, Concepts for systematic treatment of micrometastases,, Cancer, 35 (1975), 15. doi: 10.1002/1097-0142(197501)35:1<15::AID-CNCR2820350104>3.0.CO;2-W. Google Scholar
[28]	H. E. Skipper, F. M. Schaebel-Jr. and W. S. Wilcox, Experimental evaluation of potential anticancer agents XIII: on the criteria and kinetics associated with curability of experimental leukemia,, Cancer Chemother. Rep., 35 (1964), 1. Google Scholar
[29]	J. S. Spratt, J. S. Meyer and J. A. Spratt, Rates of growth of human neoplasms: part II,, J. Surg. Oncol., 61 (1996), 68. doi: 10.1002/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E. Google Scholar
[30]	G. S. Stamatakos, E. A. Kolokotroni, D. D. Dionysiou, E. C. Georgiadi and C. Desmedt, An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumour to chemotherapy: mimicking a clinical study,, J. Theor. Biol., 266 (2010), 124. doi: 10.1016/j.jtbi.2010.05.019. Google Scholar
[31]	V. G. Vaidya and F. J. Alexandro Jr., Evaluation of some mathematical models for tumor growth,, Int. J. Biom. Comput., 13 (1982), 19. doi: 10.1016/0020-7101(82)90048-4. Google Scholar
[32]	World Health Organization, http://www.who.int/cancer/en/, accessed 02/03/2012., (). Google Scholar
[33]	R. A. Weinberg, "The Biology of Cancer,'', Garland Science, (2008). Google Scholar

[1]	Luis A. Fernández, Cecilia Pola. Optimal control problems for the Gompertz model under the Norton-Simon hypothesis in chemotherapy. Discrete & Continuous Dynamical Systems - B, 2019, 24 (6) : 2577-2612. doi: 10.3934/dcdsb.2018266
[2]	Juan Pablo Aparicio, Carlos Castillo-Chávez. Mathematical modelling of tuberculosis epidemics. Mathematical Biosciences & Engineering, 2009, 6 (2) : 209-237. doi: 10.3934/mbe.2009.6.209
[3]	Urszula Ledzewicz, Behrooz Amini, Heinz Schättler. Dynamics and control of a mathematical model for metronomic chemotherapy. Mathematical Biosciences & Engineering, 2015, 12 (6) : 1257-1275. doi: 10.3934/mbe.2015.12.1257
[4]	Geoffrey Beck, Sebastien Imperiale, Patrick Joly. Mathematical modelling of multi conductor cables. Discrete & Continuous Dynamical Systems - S, 2015, 8 (3) : 521-546. doi: 10.3934/dcdss.2015.8.521
[5]	Nirav Dalal, David Greenhalgh, Xuerong Mao. Mathematical modelling of internal HIV dynamics. Discrete & Continuous Dynamical Systems - B, 2009, 12 (2) : 305-321. doi: 10.3934/dcdsb.2009.12.305
[6]	Oliver Penrose, John W. Cahn. On the mathematical modelling of cellular (discontinuous) precipitation. Discrete & Continuous Dynamical Systems - A, 2017, 37 (2) : 963-982. doi: 10.3934/dcds.2017040
[7]	Hsiu-Chuan Wei. Mathematical and numerical analysis of a mathematical model of mixed immunotherapy and chemotherapy of cancer. Discrete & Continuous Dynamical Systems - B, 2016, 21 (4) : 1279-1295. doi: 10.3934/dcdsb.2016.21.1279
[8]	Shuo Wang, Heinz Schättler. Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity. Mathematical Biosciences & Engineering, 2016, 13 (6) : 1223-1240. doi: 10.3934/mbe.2016040
[9]	Urszula Ledzewicz, Shuo Wang, Heinz Schättler, Nicolas André, Marie Amélie Heng, Eddy Pasquier. On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach. Mathematical Biosciences & Engineering, 2017, 14 (1) : 217-235. doi: 10.3934/mbe.2017014
[10]	Joseph Malinzi, Rachid Ouifki, Amina Eladdadi, Delfim F. M. Torres, K. A. Jane White. Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis. Mathematical Biosciences & Engineering, 2018, 15 (6) : 1435-1463. doi: 10.3934/mbe.2018066
[11]	Marek Bodnar, Monika Joanna Piotrowska, Magdalena Urszula Bogdańska. Mathematical analysis of a generalised model of chemotherapy for low grade gliomas. Discrete & Continuous Dynamical Systems - B, 2019, 24 (5) : 2149-2167. doi: 10.3934/dcdsb.2019088
[12]	Liumei Wu, Baojun Song, Wen Du, Jie Lou. Mathematical modelling and control of echinococcus in Qinghai province, China. Mathematical Biosciences & Engineering, 2013, 10 (2) : 425-444. doi: 10.3934/mbe.2013.10.425
[13]	Roderick Melnik, B. Lassen, L. C Lew Yan Voon, M. Willatzen, C. Galeriu. Accounting for nonlinearities in mathematical modelling of quantum dot molecules. Conference Publications, 2005, 2005 (Special) : 642-651. doi: 10.3934/proc.2005.2005.642
[14]	Luis L. Bonilla, Vincenzo Capasso, Mariano Alvaro, Manuel Carretero, Filippo Terragni. On the mathematical modelling of tumor-induced angiogenesis. Mathematical Biosciences & Engineering, 2017, 14 (1) : 45-66. doi: 10.3934/mbe.2017004
[15]	M.A.J Chaplain, G. Lolas. Mathematical modelling of cancer invasion of tissue: dynamic heterogeneity. Networks & Heterogeneous Media, 2006, 1 (3) : 399-439. doi: 10.3934/nhm.2006.1.399
[16]	Christos V. Nikolopoulos. Mathematical modelling of a mushy region formation during sulphation of calcium carbonate. Networks & Heterogeneous Media, 2014, 9 (4) : 635-654. doi: 10.3934/nhm.2014.9.635
[17]	Alexandre Cornet. Mathematical modelling of cardiac pulse wave reflections due to arterial irregularities. Mathematical Biosciences & Engineering, 2018, 15 (5) : 1055-1076. doi: 10.3934/mbe.2018047
[18]	Tinevimbo Shiri, Winston Garira, Senelani D. Musekwa. A two-strain HIV-1 mathematical model to assess the effects of chemotherapy on disease parameters. Mathematical Biosciences & Engineering, 2005, 2 (4) : 811-832. doi: 10.3934/mbe.2005.2.811
[19]	Urszula Ledzewicz, Helmut Maurer, Heinz Schättler. Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy. Mathematical Biosciences & Engineering, 2011, 8 (2) : 307-323. doi: 10.3934/mbe.2011.8.307
[20]	Clara Rojas, Juan Belmonte-Beitia, Víctor M. Pérez-García, Helmut Maurer. Dynamics and optimal control of chemotherapy for low grade gliomas: Insights from a mathematical model. Discrete & Continuous Dynamical Systems - B, 2016, 21 (6) : 1895-1915. doi: 10.3934/dcdsb.2016028

2018 Impact Factor: 1.313

American Institute of Mathematical Sciences